Catalyst Wire Dossier Catalyst Wire Dossier

MVA-BN Yellow Fever Vaccine

Modified vaccinia Ankara-BN Yellow Fever vaccine · Bavarian Nordic A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MVA-BN Yellow Fever Vaccine, covering 2026-02-09 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers [Phase 1]

See pricing